Supplemental Figure S4 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma
Year: 2024
Type: supplementary-materials
Abstract: The DNA-PKi enhancement of EWS cells sensitivity to etoposide DNA-PK inhibition is a class effect
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4401204308
